Karen Phaik Har Lim

<i>BRAF-V600E</i> expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

Marie‐Luise Berres, Karen Phaik Har Lim, Tricia Peters et al. · The Journal of Experimental Medicine · 2014 · 436 citations · Full text

Medicine, Pathobiology, Pathology +13

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis

Rikhia Chakraborty, Oliver Hampton, Xiaoyun Shen et al. · Blood · 2014 · 426 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis

Rikhia Chakraborty, Thomas M. Burke, Oliver Hampton et al. · Blood · 2016 · 169 citations · Full text

Medicine, Genetics, Molecular Genetics +9

CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH‐associated neurodegeneration and mass lesions

Kenneth L. McClain, Jennifer Picarsic, Rikhia Chakraborty et al. · Cancer · 2018 · 134 citations · Full text

Medicine, Neurology, Pathology +17

Differentiating Skin-Limited and Multisystem Langerhans Cell Histiocytosis

Stephen J. Simko, Benjamin Garmezy, Harshal Abhyankar et al. · The Journal of Pediatrics · 2014 · 102 citations

Medicine, Dermatology, Pathology +12